Japan’s first medical cannabis law may end up only legalising a single pharmaceutical product, while also criminalising recreational cannabis consumption.
The country could soon have its first medical cannabis regulation in place, allowing in theory for the use of cannabinoid-based approved medical drugs.
A new bill, which has been passed by the House of Representatives (the lower house of the Japanese parliament, or National Diet), has now been sent to the House of Councillors (the upper house) and is expected to come into effect by the end of 2024.